PeptiDream Inc.

4587.TJapan

16 filed reports · 433 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

¥18.5B

FY2025 · to Dec 31, 2025

down −60.3% vs ¥46.7B

Half-year report

Net income

-¥3.75B

FY2025 · to Dec 31, 2025

a year earlier: ¥15B

Half-year report

Operating income

-¥5.01B

FY2025 · to Dec 31, 2025

a year earlier: ¥21.1B

Annual report

Latest half year

Revenue

¥9.23B

H1 FY2026 · to Jun 30, 2026

up +8.0% vs ¥8.54B

Half-year report

Net income

-¥2B

H1 FY2026 · to Jun 30, 2026

a year earlier: -¥2.12B

Half-year report

Operating income

-¥2.53B

H1 FY2026 · to Jun 30, 2026

a year earlier: -¥2.63B

Half-year report

Filed reports

16 reports · Dec 2021 to Sep 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Annual · annual securities reportEDINET31,183Dec 2021 to Dec 2025
Half Year · half-year securities reportEDINET3640Jun 2024 to Jun 2026
Annual · amended annual securities reportEDINET2627Dec 2022 to Dec 2023
Q1 · quarterly securities reportEDINET2438Mar 2022 to Mar 2024
Q3 · quarterly securities reportEDINET2523Sep 2022 to Sep 2023
Half Year · amended quarterly securities reportEDINET1229Jun 2023
Half Year · quarterly securities reportEDINET1203Jun 2022
Q1 · amended quarterly securities reportEDINET1155Mar 2023
Q3 · quarterly earnings release (kessan tanshin)EDINET1237Sep 2026

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q3quarterly earnings release (kessan tanshin)2026-09-302026-11-11237Open
FY2026 H1half-year securities report2026-06-302026-08-12269Open
FY2025annual securities report2025-12-312026-03-18649Open
FY2025 H1half-year securities report2025-06-302025-08-07187Open
FY2024annual securities report2024-12-312025-03-28339Open
FY2024 H1half-year securities report2024-06-302024-08-09184Open
FY2024 Q1quarterly securities report2024-03-312024-05-15265Open
FY2023amended annual securities report2023-12-312024-09-25328Open
FY2023 Q3quarterly securities report2023-09-302023-11-10321Open
FY2023 H1amended quarterly securities report2023-06-302023-11-09229Open
FY2023 Q1amended quarterly securities report2023-03-312023-11-09155Open
FY2022amended annual securities report2022-12-312023-07-18299Open

Financial data

433 concepts · 4,235 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

IFRS222 concepts · 3,220 facts · Dec 2020 to Sep 2026

  • Cash and Equivalents38 · Dec 2020 to Sep 2026
  • Comprehensive Income Attributable to Owners of Parent37 · Mar 2021 to Sep 2026
  • EPS (Basic)37 · Mar 2021 to Sep 2026
  • EPS (Diluted)37 · Mar 2021 to Sep 2026
  • Net Income37 · Mar 2021 to Sep 2026
  • Pretax Income37 · Mar 2021 to Sep 2026
  • Profit Attributable to Owners of Parent37 · Mar 2021 to Sep 2026
  • Revenue37 · Mar 2021 to Sep 2026
  • Total Comprehensive Income37 · Mar 2021 to Sep 2026
  • Stockholders Equity36 · Dec 2020 to Sep 2026
  • Equity Attributable to Owners of Parent35 · Dec 2020 to Sep 2026
  • Total Assets35 · Dec 2020 to Sep 2026
  • Capital surplus (IFRS)31 · Dec 2020 to Sep 2026
  • Financing Cash Flow31 · Mar 2021 to Sep 2026
  • Intangible assets (IFRS)31 · Dec 2020 to Sep 2026
  • Inventory31 · Dec 2020 to Sep 2026
  • Investing Cash Flow31 · Mar 2021 to Sep 2026
  • Operating Cash Flow31 · Mar 2021 to Sep 2026
  • Other components of equity31 · Dec 2020 to Sep 2026
  • Other current assets - CA (IFRS)31 · Dec 2020 to Sep 2026
  • Other current liabilities - CL (IFRS)31 · Dec 2020 to Sep 2026
  • Other financial assets - CA (IFRS)31 · Dec 2020 to Sep 2026
  • Other financial assets - NCA (IFRS)31 · Dec 2020 to Sep 2026
  • Other non-current assets - NCA (IFRS)31 · Dec 2020 to Sep 2026

GAAP195 concepts · 776 facts · Dec 2019 to Dec 2025

  • EPS (Basic)8 · Dec 2019 to Dec 2025
  • Equity-to-asset ratio, Key financial data8 · Dec 2019 to Dec 2025
  • Net Assets8 · Dec 2019 to Dec 2025
  • Net assets per share8 · Dec 2019 to Dec 2025
  • Ordinary profit (loss), Key financial data8 · Dec 2019 to Dec 2025
  • Revenue8 · Dec 2019 to Dec 2025
  • Total Assets8 · Dec 2019 to Dec 2025
  • Net assets, Key financial data7 · Dec 2019 to Dec 2025
  • Net Income7 · Dec 2019 to Dec 2025
  • Number of employees7 · Dec 2019 to Dec 2025
  • Rate of return on equity, Key financial data7 · Dec 2020 to Dec 2025
  • Share capital, Key financial data7 · Dec 2019 to Dec 2025
  • Total number of issued shares7 · Dec 2019 to Dec 2025
  • Accounts payable - other6 · Dec 2020 to Dec 2025
  • Accounts payable - trade6 · Dec 2020 to Dec 2025
  • Accounts receivable - trade6 · Dec 2020 to Dec 2025
  • Accrued expenses6 · Dec 2020 to Dec 2025
  • Accumulated depreciation-buildings6 · Dec 2020 to Dec 2025
  • Accumulated depreciation-structures6 · Dec 2020 to Dec 2025
  • Accumulated depreciation-tools, furniture and fixtures6 · Dec 2020 to Dec 2025
  • Advances received6 · Dec 2020 to Dec 2025
  • Buildings6 · Dec 2020 to Dec 2025
  • Buildings, net6 · Dec 2020 to Dec 2025
  • Capital surplus6 · Dec 2020 to Dec 2025

Segment12 concepts · 231 facts · Dec 2021 to Sep 2026

  • Revenue61 · Jun 2022 to Sep 2026
  • Revenue from external customers (IFRS)47 · Jun 2022 to Sep 2026
  • Segment profit (loss)47 · Jun 2022 to Sep 2026
  • Intersegment revenue (IFRS)42 · Sep 2022 to Sep 2026
  • Number of employees13 · Dec 2021 to Dec 2025
  • Depreciation and amortization - Operating expenses (IFRS)9 · Dec 2023 to Dec 2025
  • Business combination-related expenses2 · Sep 2025 to Sep 2026
  • Finance costs (IFRS)2 · Sep 2025 to Sep 2026
  • Finance income (IFRS)2 · Sep 2025 to Sep 2026
  • Operating Income2 · Sep 2025 to Sep 2026
  • Pretax Income2 · Sep 2025 to Sep 2026
  • Share of profit (loss) of investments accounted for using equity method2 · Sep 2025 to Sep 2026

Guidance4 concepts · 8 facts · Nov 2026

  • Operating Income Guidance2 · Nov 2026
  • Pretax Income Guidance2 · Nov 2026
  • Profit Attributable to Owners of Parent Guidance2 · Nov 2026
  • Revenue Guidance2 · Nov 2026

Segments

231 facts

Figures broken down by business line, region, product or another axis the company reports on.

Operating segments6 members · 231 facts

  • RadiopharmaceuticalsBusinessReportableSegmentMember66 · Jun 2022 to Sep 2026
  • ReportableSegmentsMember62 · Jun 2022 to Sep 2026
  • DrugDiscoveryAndDevelopmentBusinessReportableSegmentMember52 · Jun 2022 to Sep 2026
  • ReconcilingItemsMember28 · Sep 2022 to Sep 2026
  • EntityTotalMember18 · Sep 2025 to Sep 2026
  • CorporateSharedMember5 · Dec 2021 to Dec 2025

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of PeptiDream Inc. (4587.T) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.